| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $43.0M | +27.6% |
| Cost of Revenue | $20.6M | -5.2% |
| Gross Profit | $22.4M | +87.0% |
| R&D Expense | $10.7M | +9.7% |
| SG&A Expense | $18.3M | +15.5% |
| Operating Income | -$54.2M | -23.3% |
| Interest Expense | $3.2M | -22.0% |
| Pre-tax Income | -$136.4M | -174.4% |
| Income Tax | $2.4M | +30.1% |
| Net Income | -$73.1M | -45.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.0M | — |
| Accounts Receivable | $6.8M | -43.2% |
| Current Assets | $43.3M | -52.9% |
| Total Assets | $168.6M | — |
| Current Liabilities | $22.7M | -87.6% |
| Long-term Debt | $73.0M | — |
| Total Liabilities | $176.8M | — |
| Stockholders' Equity |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$52.1M | -203.0% |
| Capital Expenditures | $920K | -14.3% |
| Investing Cash Flow | $124.1M | — |
| Financing Cash Flow | -$48.4M | -349.4% |
| Free Cash Flow | -$53.0M | -190.2% |
| -$8.2M |
| -1703.2% |